Chemical Casualty Care: Hydrogel Nanoparticle Aggregates as Wound Dressings Following Debridement of Cutaneuous Vesicant Injuries
Award last edited on: 2/19/2007

Sponsored Program
Awarding Agency
DOD : Army
Total Award Amount
Award Phase
Solicitation Topic Code
Principal Investigator
John V St John

Company Information

Abeona Therapeutics Inc (AKA: PlasmaTech Biopharmaceutcials Inc~Access Pharmaceuticals Inc~Chemex Corporation~Chemex Pharmaceuticals Inc)

1330 Avenue of the Americas 33rd Floor
New York, NY 20029
   (214) 905-5100
Location: Single
Congr. District: 12
County: Dallas

Phase I

Contract Number: W81XWH-06-C-0026
Start Date: 11/14/2005    Completed: 5/13/2006
Phase I year
Phase I Amount
The proposed research will demonstrate the utility of hydrogel nanoparticle aggregates as bandages for post-debridement vesicant injuries. Dehydrated hydrogel nanoparticles in powder form are applied to the surface of a wound. The nanoparticles aggregate immediately and form a continuous hydrogel film that absorbs exudate and protects the wound surface. Studies show that an aggregate film controls the release of antibiotics, painkillers, protein-based growth factors, and steroids for periods ranging from weeks to months. The research will apply the wound dressing to burns in an animal model and assess the healing and local pharmacokinetics for released therpeutics

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
Phase II Amount